Every reporter from beijing
Recently, an opinion on the draft tender for fujian province was prepared by the china society for the promotion of scientific and technical research and development of the pharmaceutical industry (hereinafter referred to as pharmacy) and the chinese association for the management of pharmaceutical enterprises. It was submitted to the office of the leading group for the central procurement of medicines in fujian (hereinafter referred to as hereinafter referred to as the fujian tender office)。
On 11 august, fujian tenders issued a draft request for advice on the procurement of medicines, and while fujian is not the province of medicine, his policy of limiting the catalogue to low prices still stings the business nerves. On the afternoon of 15 august, the deadline for the submission of the drafts of comments was also completed by the two associations, which were then sent promptly to the relevant ministries, such as the national health care and rehabilitation commission, the health and safety commission and the ministry of industry and communications。
In an interview with a journalist for daily economic news, the president of psa stated that quality had always been at the forefront of the national bid policy, but that in the fujian provincial bid price was the first step in the bidding process, continuing the low price policy. “we hope that fujian will respond and are ready to do so in further consultation and cooperation.”
According to the relevant director of the chinese association of pharmaceutical enterprises, the tender office in fujian appears to be priced only at a lower price. In fact, it is not a single priced variety that has been struck. Low-priced medicines and generics have either been abandoned or bled, and the market after the tender will become a haven for foreign medicine and high-priced medicines。
The price is lower
On 11 december, the fukuyan province's central procurement implementation programme for medicines in medical institutions for 2014 (advisory draft) launched a web-based consultation and tendered for essential and non-essential medicines in public health institutions in the province。
In the last round of drug tenders, the embot model was introduced as a template. Since then, there have been “quality doors” that have led to the non-conformity of medicines for low-priced winnings, and the emboss model has given rise to reflection. Quality was also taken into account in this round of bidding, with the provinces of hunan, hubei and hebei no longer emphasizing the lowest price mark and the province of anhui beginning to correct it. In this context, the bid policy of fujian province, which is priced at lower prices, has triggered a rebound in the industry。
According to the consultation draft of fujian province, the maximum price limit for medicines is based on the lowest winning bid for the central procurement of medicines at the provincial level since 1 january 2011. In the bidding process, exclusive and non-exclusive varieties are tendered at different levels. The tender is based on a two-envelope system, with priority given to commercial tenders. This means that the bidding firm will start a price war first and take quality into account on a sufficiently low price basis。
The responsible director of the medical enterprise management association stated that, while the nominally fukuya tender was price-only, the substance was not limited to it, that the tender splits the products of the enterprise into two levels, that the overwhelming majority of the hit was at the second level, and that the maximum price for medicines in fujian province was already well below the cost line, owing to, inter alia, the new version of the gmp certification and the increase in the price of raw materials, which would result in most of the products not being priced separately。
Low-cost drugs are lost
As a separate priced variety at another level, the absence of a rival would allow exclusive businesses to dominate the market, which would significantly increase health-care costs and increase the burden on the population. Owing to the high price and scope of operation of separate priced varieties, doctors are encouraged to choose the preferred option. The market after the tender will become a haven for foreign medicine and high-priced medicines; low-cost drugs, imitating medicines, or giving up or bleeding, may be abandoned by hospital doctors or even lost to other markets throughout the country。
In an interview with the vice-president of the provocacy industry, tanya, it was stated that businesses with non-exclusive varieties would abandon sales in the region in order to protect other markets。
In addition, double-envelope bidding for low-priced medicines would further increase the price of low-priced medicines. In may of this year, cdi and the provinces and municipalities successively launched a national and provincial catalogue of low-cost medicines; in july, the commission issued a circular on the management of the procurement of common low-cost drugs, which states that the common low-cost medicines used in public hospitals are negotiated and settled in a timely manner by the hospital directly with the internet-based producers。
In this case, fujian province requested that the municipalities, the pyramid complex and provincial medical institutions evaluate the purchase of generic low-price drugs directly connected to the internet, using a “two envelope” based on the established reference price and the company's offer。
This means that even drugs that enter a low-cost catalogue are subject to price killings. The opinion of the two associations states that it is because of lower prices, the reluctance of enterprises to produce and the inability to meet the clinical needs of patients that the state has issued documents on the guarantee of access to low-cost medicines. If price matches are repeated, it is clear that the spirit of the state regarding the security of supply of commonly used low-cost medicines is inconsistent with the incentive to direct and mobilize enterprises to produce and supply commonly used low-cost medicines。
The restricted catalogue is referred to as intervention in the market
In addition to prices, the establishment of the catalogue threshold is another controversial feature of this fujian tender policy. According to the consultation draft, nearly 3,000 varieties were tendered from the state, based on the list of essential drugs, the medical insurance scheme of fujian province and the reimbursement catalogue of new agripharmaceutical drugs, and based on the principle of meeting clinical needs, a list of central purchases of medicines was selected by experts. The regional procurement catalogue shall be established in the context of the provincial procurement directory, in the municipalities of the districts, in the pyramid complex and in provincial medical establishments, on the basis of the type of common disease, level of health insurance payments, medical practice, etc。
According to the two major pharmaceutical associations, this has led to excessive government intervention in the drug trade, artificially setting up market-trading barriers and raising market access thresholds beyond those required by laws and regulations。
A medical marketing expert, who was reluctant to reveal his name, said that 3,000 varieties basically covered commonly used medicines, but that meant that many medicines were squeezed out of the catalogue and that even entering the catalogue did not mean being able to participate in the bidding process, since in many cases not only restricted the variety but also the type and size of the agent, which often varied。
Responsible editor: zhang dei
[whispering information cellular client downloading]
